Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120420) titled 'A randomized controlled trial of different doses of tegiletidine versus sufentanil for postoperative patient-controlled intravenous analgesia (PCIA) in patients with gynecological malignancies undergoing laparoscopic surgery' on March 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Cancer Hospital of Guizhou Medical University
Condition:
Postoperative Analgesia
Intervention:
Group T1:Loading dose: Tegiletidine fumarate 1 mg was slowly administered via intravenous pump infusion 30 minutes before the end of surgery. PCIA regimen: Telitacicept fumarate 2.5 mg+ tropiset...